PATIENT INFORMATION LEAFLET
Quetiapina Pharma Combix 400 mg prolonged-release tablets EFG
Read this leaflet carefully before you start taking this medicine,because it contains important information for you.
1.What Quetiapina Pharma Combix is and what it is used for
2.What you need to know before taking Quetiapina Pharma Combix
3.How to take Quetiapina Pharma Combix
4.Possible side effects
5.Storage of Quetiapina Pharma Combix
6.Contents of the pack and additional information
Quetiapina Pharma Combix contains a substance called quetiapine. It belongs to a group of medicines called antipsychotics. Quetiapina Pharma Combix may be used to treat several conditions, such as:
When using Quetiapina Pharma Combix,to treat major depressive episodes in major depressive disorder, this will be taken in addition to another medicine that is already being used to treat this condition.
Your doctor may continue prescribing Quetiapina Pharma Combix,even when you are feeling better.
Do not takeQuetiapina Pharma Combix:
-some HIV medications
-azole-type medications (for fungal infections)
-erythromycin or clarithromycin (for infections)
-nefazodone (for depression).
Do not take Quetiapina Pharma Combix,if the above-mentioned applies to you. If you have any doubts, consult your doctor or pharmacist before taking Quetiapina Pharma Combix.
Warnings and precautions
Consult your doctoror pharmacistbefore starting to take Quetiapina Pharma Combix,if:
The use of these medications with quetiapine may cause serotonin syndrome, a potentially life-threatening condition (see "Use of Quetiapina Pharma Combix with other medications").
Inform your doctor immediately if after taking Quetiapina Pharma Combix you experience any of the following:
These conditions may be caused by this type of medication.
Inform your doctor as soon as possible if you have:
Thoughts of suicide and worsening of depression
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase at the beginning of treatment, as all these medications take time to take effect, usually around two weeks but sometimes longer. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information from clinical trials has shown an increased risk of thoughts of suicide and/or suicidal behavior in young adults under 25 with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You can ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should regularly monitor your weight.
Children and adolescents
Quetiapina Pharma Combix should not be used in children and adolescents under 18 years of age.
Use of Quetiapina Pharma Combix with other medications
Inform your doctor if you are taking, have taken recently, or may need to take any other medication.
Do not take Quetiapina Pharma Combix if you are using any of the following medications:
Inform your doctor if you are using any of the following medications:
Before stopping any of your medications, consult your doctor first.
Taking Quetiapina Pharma Combix with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication. Do not takeQuetiapina Pharma Combixduring pregnancy, unless you have consulted your doctor. Do not useQuetiapina Pharma Combixif you are breastfeeding.
The following symptoms,which may represent withdrawal syndrome,may appear in newborn babies of mothers who have used quetiapine in the last trimester (last three months of pregnancy): tremor, muscle stiffness, and/or weakness, drowsiness, agitation, respiratory problems, and feeding difficulties. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machinery
Quetiapine may cause symptoms such as drowsiness, dizziness, or visual disturbances, and may impair your ability to react. These effects, as well as the underlying condition, may make it difficult for you to drive vehicles or operate machinery. Therefore, do not drive, operate machinery, or engage in other activities that require special attention, until your doctor assesses your response to this medication.
Effect on Drug Detection Tests in Urine
If you are undergoing a urine drug detection test, taking quetiapine may produce positive results for methadone or certain antidepressant medications known as tricyclic antidepressants (TCAs) when using certain analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your illness and your needs, but it will normally be between 150mg and 800mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Older adults
If you are an older adult, your doctor may change your dose.
Use in children and adolescents
Quetiapina Pharma Combixshould not be used in children and adolescents under 18 years of age.
If you take moreQuetiapina Pharma Combixthan you should
If you take moreQuetiapina Pharma Combixthan your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or the nearest hospital immediately. Bring your Quetiapina Pharma Combix tablets with you.
You can also call the Toxicological Information Service, Tf: 915620420, indicating the medication and the amount taken.
If you forget to takeQuetiapina Pharma Combix
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed dose.
If you interrupt treatment withQuetiapina Pharma Combix
If you stop taking Quetiapina Pharma Combix abruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before interrupting treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Very rare side effects(may affect up to 1 in 10,000 people):
Not known(the frequency cannot be estimated from the available data):
The class of medicines to which Quetiapina Pharma Combix belongs may cause serious heart rhythm problems that can be life-threatening in severe cases.
Some side effects are only seen when a blood test is done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increased liver enzymes, decreased numbers of certain types of blood cells, decreased red blood cells, increased creatine phosphokinase in the blood (a substance found in muscles), decreased sodium in the blood, and increased prolactin hormone in the blood. Elevated prolactin levels may, in rare cases, lead to:
Your doctor may ask you to have blood tests from time to time.
Side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common side effects(may affect more than 1 in 10 people):
Both boys and girls experiencing breast swelling and unexpected milk production.
Girls not having a menstrual period or having irregular periods.
Common side effects(may affect up to 1 in 10 people):
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSistema Español de Farmacovigilancia de Medicamentos de Uso Humano: https//www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
For the presentation in a bottle: discard the product 60 days after opening the packaging.
This medication does not require any special temperature for conservation.
Store in the original packaging to protect it from humidity.
Medications should not be thrown down the drains or in the trash. Deposit the containers and medications you no longer need at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. In this way, you will help protect the environment.
Composition ofQuetiapina Pharma Combix
Appearance of the product and contents of the packaging
The tablets of this medication are white, capsule-shaped, film-coated, and engraved with “Q 400” on one face and smooth on the other.
The available packaging are:
Aluminum/PVC/PVDC blister. Packets containing 60 tablets.
White opaque high-density polyethylene bottle with a white opaque polypropylene cap and desiccant. Pack containing 60 tablets.
Only some packaging sizes may be marketed.
Marketing Authorization Holder
Laboratorios Combix, S.L.U.
C/ Badajoz 2, Edificio 2
28223 Pozuelo de Alarcón, Madrid
Spain
Responsible for manufacturing
Merckle GmbH
Ludwig-Merckle Strasse 3
D-89143 Blaubeuren-Weiler
Germany
Last review date of the leaflet: July 2024
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.